Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Gene therapy in the Czech Republic].

¹Ustav hematologie a krevní transfuze, Praha. vonka@uhkt.cz

Casopis Lekaru Ceskych

|November 12, 2003

Summary

Gene therapy holds great medical promise but faces technical, ethical, and regulatory hurdles in the Czech Republic. Addressing these challenges could enable clinical applications soon.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Relationship of Kynurenine and Neopterin Levels and Their Association with a Selection of Other Immune Markers in Chronic Myeloid Leukaemia Patients.

Folia biologica·2017

Same author

IL-2 as adjuvant for vaccination with cells malignantly converted by HPV 16 or 3-MC.

International journal of oncology·2011

Same author

[Will vaccines appear on the scene of oncology in the near future?].

Vnitrni lekarstvi·2010

Same author

In vitro and in vivo effects of reovirus on HPV16-transformed mice cells.

Neoplasma·2010

Same author

Isolation and properties of gene-modified mouse bcr-abl-transformed cells expressing various immunostimulatory factors.

Neoplasma·2009

Same author

Immunological profiles of patients with chronic myeloid leukaemia. I. State before the start of treatment.

Folia biologica·2006

Area of Science:

Molecular biology and genetic engineering applications in medicine.

Context:

Gene therapy research in the Czech Republic is advanced, but clinical translation is hindered.
Current limitations include a lack of specific legislation, inadequate Good Manufacturing Practice (GMP) compliant production facilities, and insufficient regulatory expertise.

Purpose:

To identify and propose solutions for the technical, methodological, and ethical barriers impeding gene therapy implementation in the Czech Republic.
To outline necessary actions for advancing gene therapy from research to clinical practice.

Summary:

The Czech Republic possesses strong gene therapy research capabilities but lacks the legal framework, GMP-certified production, and qualified regulatory bodies for clinical trials.
Proposed actions aim to overcome these obstacles, facilitating the integration of gene therapy into the national healthcare system.

Impact:

Successful implementation of proposed actions will enable clinical trials and patient access to novel gene-based therapies.
Growing interest from clinicians and the public suggests a favorable outlook for gene therapy adoption in the Czech Republic.

Related Experiment Videos